Teladoc Health’s (TDOC) Hold Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC restated their hold rating on shares of Teladoc Health (NYSE:TDOC) in a research report released on Thursday morning,Benzinga reports.

Other equities analysts have also issued research reports about the company. The Goldman Sachs Group lifted their price target on Teladoc Health from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Tuesday, February 18th. Bank of America lifted their price target on Teladoc Health from $11.50 to $13.50 and gave the company a “neutral” rating in a research note on Wednesday, February 12th. Deutsche Bank Aktiengesellschaft boosted their price objective on Teladoc Health from $10.00 to $12.00 and gave the stock a “hold” rating in a research report on Friday, November 1st. Royal Bank of Canada boosted their price objective on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Finally, Piper Sandler restated an “overweight” rating and set a $13.00 price objective (up previously from $11.00) on shares of Teladoc Health in a research report on Wednesday, December 4th. Eleven analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat.com, Teladoc Health has a consensus rating of “Hold” and an average target price of $11.44.

Teladoc Health Trading Up 0.6 %

Shares of TDOC opened at $9.56 on Thursday. Teladoc Health has a 52-week low of $6.76 and a 52-week high of $15.95. The business’s fifty day moving average is $10.62 and its 200-day moving average is $9.57. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.69 and a current ratio of 1.73. The firm has a market cap of $1.65 billion, a price-to-earnings ratio of -1.66 and a beta of 1.05.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The business had revenue of $640.49 million during the quarter, compared to the consensus estimate of $639.44 million. Equities analysts anticipate that Teladoc Health will post -1.16 EPS for the current fiscal year.

Insider Activity at Teladoc Health

In related news, insider Carlos Nueno sold 2,389 shares of the company’s stock in a transaction dated Monday, December 2nd. The stock was sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. This represents a 45.25 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.95% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On Teladoc Health

Institutional investors and hedge funds have recently made changes to their positions in the business. Point72 Asset Management L.P. boosted its holdings in Teladoc Health by 57.8% in the third quarter. Point72 Asset Management L.P. now owns 8,366,295 shares of the health services provider’s stock worth $76,803,000 after acquiring an additional 3,063,172 shares in the last quarter. Maple Rock Capital Partners Inc. boosted its holdings in Teladoc Health by 189.5% in the fourth quarter. Maple Rock Capital Partners Inc. now owns 3,561,000 shares of the health services provider’s stock worth $32,369,000 after acquiring an additional 2,331,000 shares in the last quarter. Two Sigma Investments LP bought a new position in Teladoc Health in the fourth quarter worth approximately $18,348,000. Two Sigma Advisers LP boosted its holdings in Teladoc Health by 213.0% in the fourth quarter. Two Sigma Advisers LP now owns 2,258,711 shares of the health services provider’s stock worth $20,532,000 after acquiring an additional 1,537,094 shares in the last quarter. Finally, Vanguard Group Inc. boosted its holdings in Teladoc Health by 5.9% in the fourth quarter. Vanguard Group Inc. now owns 18,463,155 shares of the health services provider’s stock worth $167,830,000 after acquiring an additional 1,029,829 shares in the last quarter. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.